Emla and Zieve syndrome - a phase IV clinical study of FDA data

Summary:

We study 4,665 people who take Emla or have Zieve syndrome. No report of Zieve syndrome is found in people who take Emla.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 30, 2023

No report is found.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 4,653 Emla users for its effectiveness, alternative drugs and more.

What is Zieve Syndrome?

Zieve syndrome (the combination of alcoholic infection of liver ,destruction of blood cells jaundice) is found to be associated with 15 drugs and 6 conditions by eHealthMe.

Do you take Emla and have Zieve syndrome?

Check whether Zieve syndrome is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Zieve syndrome and when was it recovered:

Zieve syndrome in Emla

Expand to all the drugs that have ingredients of lidocaine; prilocaine:

Zieve syndrome and drugs with ingredients of lidocaine; prilocaine

Alternative drugs to, pros and cons of Emla:

Emla (4,653 reports)

Zieve syndrome treatments and more:

Zieve syndrome (12 reports)

COVID vaccines that are related to Zieve syndrome:

All the drugs that are associated with Zieve syndrome:

Zieve syndrome

All the conditions that are associated with Zieve syndrome:

Zieve syndrome

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine; prilocaine (the active ingredients of Emla) and Emla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.